Mumbai, June 30 -- Biocon Biologics(BBL) announced that its Malaysian subsidiary, Biocon Sdn. Bhd., has surpassed the milestone of supplying 100 million cartridges of recombinant human insulin (rh-insulin) to Malaysia's Ministry of Health (MoH). This achievement reinforces Biocon Biologics' long-standing commitment to advancing diabetes care and ensuring affordable access to insulin across the country.
Published by HT Digital Content Services with permission from Capital Market....